Greater Midwest Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Greater Midwest Financial Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,206	Closed	-$2.03M	–	64
2025 Q1	$2.03M	Buy	3,206 +98	+3%	+$67.4K	1.42%	21
2024 Q4	$2.21M	Buy	3,108 +588	+23%	+$493K	1.4%	19
2024 Q3	$2.65M	Buy	2,520 +18	+0.7%	+$20K	1.55%	18
2024 Q2	$2.89M	Buy	2,502 +203	+9%	+$197K	1.83%	16
2024 Q1	$2.21M	Buy	2,299 +32	+1%	+$30.4K	1.39%	17
2023 Q4	$1.99M	Buy	+2,267	New	+$1.87M	1.35%	18

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Greater Midwest Financial Group's REGN Position: Q2 2025 in Review

Greater Midwest Financial Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 3,206 shares — an estimated $2.03M sold.

Greater Midwest Financial Group first reported a position in REGN in Q4 2023 and held it in 6 quarters. The position peaked at $2.89M in Q2 2024. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

Greater Midwest Financial Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Greater Midwest Financial Group sold 3,206 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $2.03M.
Greater Midwest Financial Group first reported a position in Regeneron Pharmaceuticals in Q4 2023 and held it in 6 quarters.
Greater Midwest Financial Group's Regeneron Pharmaceuticals position peaked at $2.89M in Q2 2024.
1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Greater Midwest Financial Group's 13F filing for Q2 2025, filed 5 Aug 2025.